Skip to content

Evommune EVMN Total debt

Total debt at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$5.04B+4.3%
BillionToOne, Inc.
 logo
BillionToOne, Inc. BLLN
$144.19M
Perrigo Company logo
Perrigo CompanyPRGO
$3.83B-0.6%
Hims & Hers Health logo
Hims & Hers HealthHIMS
$157.93M+149%
Pfizer logo
PfizerPFE

Other financials

Income statement

See full
Revenue$1.6M+3.5%
Gross profit$961.1K+10.9%
Operating income-$682.8K-2,027%
Net income-$7.0M-5,414%
EPS (diluted)-$0.36-1,700%

Balance sheet

See full
Cash & equivalents$1.1M+401%
Total equity-$4.5M-3,048%
Total assets$7.2M

Cash flow

See full
Operating cash flow-$424.6K-341%
CapEx$1.0-99.8%
Free cash flow-$2.7M-4,996%

Valuation

See full
Market cap$848.59M+39.5%
Enterprise value$849.52M
P/S127.3×

Profitability

See full
Gross margin53.7%
Operating margin-30.7%
Net margin-90.1%

Returns & leverage

See full
Return on equity275.7%
Debt / equity1.4×
Current ratio1.2×

Where this comes from

Calculated from Evommune ’s reported figures.

Plus components not separately reported this period.

The official record: Evommune ’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Evommune 's total debt?
Evommune (EVMN) reported total debt of $2M in Q1 2026.
What is the long-term trend for Evommune 's total debt?
Over 2 years (2023 to 2025), Evommune 's total debt has grown at a -6.4% compound annual growth rate (CAGR), from $2.4M to $2.1M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.